Leukemia Research
Volume 27, Issue 6 , Pages 475-479 , June 2003

Empirical examination of the neutrophil criterion (>1500 μl−1) currently needed to declare CR in AML

Received 9 January 2003 ,Accepted 24 January 2003.

References 

  1. Cheson BD, Cassileth PA, Head DR. Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J. Clin. Oncol. 1990;8:813
  2. Estey EH, Kantarjian HM, Cortes JE, Thomas D, Verstovsek S, Pierce S, et al.  Is the absence of circulating blasts a valid criterion for CR in AML?. Blood. 2002;88a:100; [abstract #324]
  3. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al.  Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French–American–British Cooperative Group. Ann. Int. Med. 1985;103:620–625
  4. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, et al.  World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting, Airlie House, VA, November 1997. J. Clin. Oncol. 1999;17:3835–3849
  5. Estey E, Thall P, Beran M, Kantarjian H, Pierce S, Keating M. Effect of diagnosis (refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, or acute myeloid leukemia (AML)) on outcome of AML-type chemotherapy. Blood. 1997;90:2969–2977
  6. Holmes RI, Keating MJ, Cork A, Trujillo JM, McCredie KB, Freireich EJ. Loss of the Y chromosome in acute myelogenous leukemia: a report of 13 patients. Cancer Genet. Cytogenet. 1985;17:269–278
  7. Estey EH, Thall PF, Cortes JE, Giles FJ, O’Brien S, Pierce SA, et al.  Comparison of idarubicin + ara-C-, fludarabine + ara-C-, and topotecan + ara-C-based regimens in treatment of newly-diagnosed acute myeloid leukemia, refractory anemia with excess blasts in transformation, or refractory anemia with excess blasts. Blood. 2001;98:3575–3583
  8. Grimwade D, Walker H, Harrison G, Oliver F, Chatters S, Harrison CJ, et al.  On behalf of the Medical Research Council Adult Leukemia Working Party: the predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML), analysis of 1065 patients entered into the UK Medical Research Council AML 11 trial. Blood. 2001;98:1312–1320

PII: S0145-2126(03)00031-6

doi: 10.1016/S0145-2126(03)00031-6

Leukemia Research
Volume 27, Issue 6 , Pages 475-479 , June 2003

Article Tools

* Image Usage & Resolution